RxDoctor Payments Data

Cari Stefani

Psychiatric/Mental Health · Waterloo, ILNPI 1508286477

Payments from drug & device makers

$627in general payments, 2019–2025

Across 31 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$209
  • AbbVie$208
  • E.r. Squibb & Sons, L.L.C.$49
  • Otsuka America Pharmaceutical, Inc.$42
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$23
  • Alkermes, Inc.$22
  • plus $73 from 4 others

What the payments were for

  • Food & beverage$51783%
  • Education$10917%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$627 in reported general payments places this provider in the 55th percentile of 922 psychiatric/mental health providers in Illinois.

See all psychiatric/mental health providers in Illinois

Medicare billing

Part B allowed, 2024
$7,814
Medicare patients
46
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine26$205,892
IngrezzaValbenazine Tosylate16$138,590
Invega SustennaPaliperidone Palmitate21$67,873
VraylarCariprazine Hcl33$46,734
FanaptIloperidone13$31,732
Lurasidone Hcl28$5,529
Clozapine OdtClozapine18$4,483
Aripiprazole35$3,935
Clozapine41$3,613
Doxepin Hcl32$3,424
Bupropion XlBupropion Hcl150$2,365
Ziprasidone Hcl25$2,304
Hydroxyzine Pamoate123$1,942
Trazodone Hcl145$1,563
Prazosin Hcl69$1,496

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$209$205,89226 claims
Neurocrine Biosciences, Inc.Ingrezza$19$138,59016 claims
Johnson & JohnsonInvega Sustenna$19$67,87321 claims
AbbVieVraylar$208$46,73433 claims
Vanda Pharmaceuticals Inc.Fanapt$15$31,73213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 922 psychiatric/mental health providers in Illinois.

Other psychiatric/mental health in Waterloo

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →